American International Group’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-800
Closed -$96 3225
2021
Q1
$96 Buy
800
+2
+0.3% +$290 ﹤0.01% 2743
2020
Q4
$104 Sell
798
-23
-3% -$2.97K ﹤0.01% 2644
2020
Q3
$87K Sell
821
-19
-2% -$2.34K ﹤0.01% 2598
2020
Q2
$216K Buy
840
+129
+18% +$49.1K ﹤0.01% 2075
2020
Q1
$316K Sell
711
-24
-3% -$12.8K ﹤0.01% 1656
2019
Q4
$497K Buy
735
+577
+365% +$289K ﹤0.01% 1697
2019
Q3
$58K Buy
158
+5
+3% +$1.63K ﹤0.01% 2854
2019
Q2
$28K Buy
+153
New +$31.8K ﹤0.01% 3030

Other funds holding NXTC

American International Group's NXTC Position: Q2 2021 in Review

American International Group sold out of NextCure (NXTC) in Q2 2021, closing a stake of 800 shares — an estimated $96 sold.

American International Group first reported a position in NXTC in Q2 2019 and held it in 8 quarters. The position peaked at $497K in Q4 2019. 78 funds tracked by Wall St. Rank hold NXTC as of Q2 2021.

  • American International Group reported no remaining NextCure position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 800 NextCure shares in Q2 2021, an estimated $96.
  • American International Group first reported a position in NextCure in Q2 2019 and held it in 8 quarters.
  • American International Group's NextCure position peaked at $497K in Q4 2019.
  • 78 funds tracked by Wall St. Rank held NextCure as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.